Stocks News

LAST PRICE
50.5000
TODAY'S CHANGE (%)
Trending Up0.0800 (0.1587%)

Bid / Lots
49.7500/ 2
Ask / Lots
51.6100/ 1
Open / Previous Close
50.0600 / 50.4200
Day Range
Low 49.9200
High 51.1000
52 Week Range
Low 18.0000
High 51.1000
Volume
1,346,752
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: RVMD
  
  Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024
  
  REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the third quarter 2024 on Wednesday, November 6, 2024, after market close. At 4:30 p.m. Eastern Time that day (1:30 p.m. Pacific Time), members of Revolution Medicines' senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress.
Oct 28, 2024
- DJ Revolution Medicines Is Maintained at Buy by Guggenheim, from 12:49PM ET on Monday Oct 28, 2024 by Dow Jones
  12:49PM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 28, 2024 12:49 ET (16:49 GMT)
- DJ Revolution Medicines Is Maintained at Outperform by Oppenheimer, from 8:58AM ET on Monday Oct 28, 2024 by Dow Jones
  8:58AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 28, 2024 08:58 ET (12:58 GMT)
- DJ Revolution Medicines Price Target Maintained With a $61.00/Share by Needham, from 8:13AM ET on Monday Oct 28, 2024 by Dow Jones
  8:13AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 28, 2024 08:13 ET (12:13 GMT)
Oct 25, 2024
- DJ Revolution Medicines Price Target Maintained With a $61.00/Share by Needham, from 4:03PM ET on Friday Oct 25, 2024 by Dow Jones
  4:03PM ET on Friday Oct 25, 2024 by Dow Jones
  Companies Mentioned: RVMD
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 25, 2024 16:03 ET (20:03 GMT)

Oct 29, 2024
- European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading, from 11:12AM ET on Tuesday Oct 29, 2024 by MT Newswires
  11:12AM ET on Tuesday Oct 29, 2024 by MT Newswires
  Companies Mentioned: HSBC, NOK, PSO, VOD, OPRA, DAVA, GNFT, AKTX, BP, CRTO, TCBP, MTLS, DBVT, ASND, SAN, BDRX
- DJ Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital, from 10:24AM ET on Tuesday Oct 29, 2024 by Dow Jones
  10:24AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: LEGN
- Viking Therapeutics Insider Sold Shares Worth $10,089,164, According to a Recent SEC Filing, from 3:02AM ET on Tuesday Oct 29, 2024 by MT Newswires
  3:02AM ET on Tuesday Oct 29, 2024 by MT Newswires
  Companies Mentioned: VKTX
Oct 28, 2024
- Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek(R) 2024, from 4:05PM ET on Monday Oct 28, 2024 by PR Newswire
  4:05PM ET on Monday Oct 28, 2024 by PR Newswire
  Companies Mentioned: VKTX
- Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek(R) 2024, from 4:05PM ET on Monday Oct 28, 2024 by Dow Jones
  4:05PM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: VKTX
- European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading, from 11:16AM ET on Monday Oct 28, 2024 by MT Newswires
  11:16AM ET on Monday Oct 28, 2024 by MT Newswires
  Companies Mentioned: LYG, PHG, VEON, EQNR, TRIB, NCNA, BP, SHEL, MTLS, DBVT, ASND, CUK, CLLS, ADAP, BDRX, EDAP
- Viking Therapeutics Insider Sold Shares Worth $1,272,000, According to a Recent SEC Filing, from 3:22AM ET on Monday Oct 28, 2024 by MT Newswires
  3:22AM ET on Monday Oct 28, 2024 by MT Newswires
  Companies Mentioned: VKTX
Oct 24, 2024
- Sector Update: Health Care Stocks Decline Late Afternoon, from 4:14PM ET on Thursday Oct 24, 2024 by MT Newswires
  4:14PM ET on Thursday Oct 24, 2024 by MT Newswires
  Companies Mentioned: MOH, MNPR, MRNS, VKTX
- Sector Update: Health Care Stocks Decline Thursday Afternoon, from 1:47PM ET on Thursday Oct 24, 2024 by MT Newswires
  1:47PM ET on Thursday Oct 24, 2024 by MT Newswires
  Companies Mentioned: MOH, WST, VKTX
- Update: Viking Therapeutics Shares Rise Following Q3 Results, from 12:05PM ET on Thursday Oct 24, 2024 by MT Newswires
  12:05PM ET on Thursday Oct 24, 2024 by MT Newswires
  Companies Mentioned: VKTX

Revolution Medicines Inc
NASDAQ:RVMDUnited States

Search Criteria

Yesterday

Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024, from 8 hours ago by Dow Jones

Oct 28, 2024

DJ Revolution Medicines Is Maintained at Buy by Guggenheim, from 12:49PM ET on Monday Oct 28, 2024 by Dow Jones

DJ Revolution Medicines Is Maintained at Outperform by Oppenheimer, from 8:58AM ET on Monday Oct 28, 2024 by Dow Jones

DJ Revolution Medicines Price Target Maintained With a $61.00/Share by Needham, from 8:13AM ET on Monday Oct 28, 2024 by Dow Jones

Oct 25, 2024

DJ Revolution Medicines Price Target Maintained With a $61.00/Share by Needham, from 4:03PM ET on Friday Oct 25, 2024 by Dow Jones

Peers Headlines

Oct 29, 2024

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading, from 11:12AM ET on Tuesday Oct 29, 2024 by MT Newswires

DJ Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital, from 10:24AM ET on Tuesday Oct 29, 2024 by Dow Jones

Viking Therapeutics Insider Sold Shares Worth $10,089,164, According to a Recent SEC Filing, from 3:02AM ET on Tuesday Oct 29, 2024 by MT Newswires

Oct 28, 2024

Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek(R) 2024, from 4:05PM ET on Monday Oct 28, 2024 by PR Newswire

Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek(R) 2024, from 4:05PM ET on Monday Oct 28, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading, from 11:16AM ET on Monday Oct 28, 2024 by MT Newswires

Viking Therapeutics Insider Sold Shares Worth $1,272,000, According to a Recent SEC Filing, from 3:22AM ET on Monday Oct 28, 2024 by MT Newswires

Oct 24, 2024

Sector Update: Health Care Stocks Decline Late Afternoon, from 4:14PM ET on Thursday Oct 24, 2024 by MT Newswires

Sector Update: Health Care Stocks Decline Thursday Afternoon, from 1:47PM ET on Thursday Oct 24, 2024 by MT Newswires

Update: Viking Therapeutics Shares Rise Following Q3 Results, from 12:05PM ET on Thursday Oct 24, 2024 by MT Newswires